HomeHealthcare & Life Sciences Psilocybin Assisted Therapy Market

Psilocybin Assisted Therapy Market Size, Share, Demand Report By Treatment Type (TRD, MDD, PTSD, Anxiety Disorders, Substance Use Disorders), By Formulation (Synthetic Psilocybin, Natural Psilocybin Extracts), By End-Use (Specialized Clinics, Hospitals, Research Institutions), By Distribution Channel, By Region & Forecasts, 2025-2033

Starting From
USD 3950
Buy Now

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.

  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.

  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

  • Track sales in the global and country-specific Market.

  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Psilocybin Assisted Therapy Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Psilocybin Assisted Therapy Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Psilocybin Assisted Therapy Market, By Treatment Type:
    1. Introduction
      1. Market Size and Forecast, By Treatment Type:
    2. TRD
      1. Market Size and Forecast, By Region
    3. MDD
      1. Market Size and Forecast, By Region
    4. PTSD
      1. Market Size and Forecast, By Region
    5. Anxiety Disorders
      1. Market Size and Forecast, By Region
    6. Substance Use Disorders
      1. Market Size and Forecast, By Region
  10. Psilocybin Assisted Therapy Market, By Formulation:
    1. Introduction
      1. Market Size and Forecast, By Formulation:
    2. Synthetic Psilocybin
      1. Market Size and Forecast, By Region
    3. Natural Psilocybin
      1. Market Size and Forecast, By Region
  11. Psilocybin Assisted Therapy Market, By End-Use:
    1. Introduction
      1. Market Size and Forecast, By End-Use:
    2. Hospitals
      1. Market Size and Forecast, By Region
    3. Specialized Clinics
      1. Market Size and Forecast, By Region
    4. Research Institutions
      1. Market Size and Forecast, By Region
  12. Psilocybin Assisted Therapy Market, By Distribution Channel:
    1. Introduction
      1. Market Size and Forecast, By Distribution Channel:
    2. Direct Clinical Distribution
      1. Market Size and Forecast, By Region
    3. Research Supply Channels
      1. Market Size and Forecast, By Region
  13. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. By Treatment Type:
          1. TRD
            1. MDD
              1. PTSD
                1. Anxiety Disorders
                  1. Substance Use Disorders
                  2. By Formulation:
                    1. Synthetic Psilocybin
                      1. Natural Psilocybin
                      2. By End-Use:
                        1. Hospitals
                          1. Specialized Clinics
                            1. Research Institutions
                            2. By Distribution Channel:
                              1. Direct Clinical Distribution
                                1. Research Supply Channels
                              2. U.S.
                                1. By Treatment Type:
                                  1. TRD
                                    1. MDD
                                      1. PTSD
                                        1. Anxiety Disorders
                                          1. Substance Use Disorders
                                          2. By Formulation:
                                            1. Synthetic Psilocybin
                                              1. Natural Psilocybin
                                              2. By End-Use:
                                                1. Hospitals
                                                  1. Specialized Clinics
                                                    1. Research Institutions
                                                    2. By Distribution Channel:
                                                      1. Direct Clinical Distribution
                                                        1. Research Supply Channels
                                                      2. Canada
                                                    3. Europe
                                                      1. Market Size and Forecast
                                                        1. By Treatment Type:
                                                          1. TRD
                                                            1. MDD
                                                              1. PTSD
                                                                1. Anxiety Disorders
                                                                  1. Substance Use Disorders
                                                                  2. By Formulation:
                                                                    1. Synthetic Psilocybin
                                                                      1. Natural Psilocybin
                                                                      2. By End-Use:
                                                                        1. Hospitals
                                                                          1. Specialized Clinics
                                                                            1. Research Institutions
                                                                            2. By Distribution Channel:
                                                                              1. Direct Clinical Distribution
                                                                                1. Research Supply Channels
                                                                              2. U.K.
                                                                                1. By Treatment Type:
                                                                                  1. TRD
                                                                                    1. MDD
                                                                                      1. PTSD
                                                                                        1. Anxiety Disorders
                                                                                          1. Substance Use Disorders
                                                                                          2. By Formulation:
                                                                                            1. Synthetic Psilocybin
                                                                                              1. Natural Psilocybin
                                                                                              2. By End-Use:
                                                                                                1. Hospitals
                                                                                                  1. Specialized Clinics
                                                                                                    1. Research Institutions
                                                                                                    2. By Distribution Channel:
                                                                                                      1. Direct Clinical Distribution
                                                                                                        1. Research Supply Channels
                                                                                                      2. Germany
                                                                                                      3. France
                                                                                                      4. Spain
                                                                                                      5. Italy
                                                                                                      6. Russia
                                                                                                      7. Nordic
                                                                                                      8. Benelux
                                                                                                      9. Rest of Europe
                                                                                                    3. APAC
                                                                                                      1. Market Size and Forecast
                                                                                                        1. By Treatment Type:
                                                                                                          1. TRD
                                                                                                            1. MDD
                                                                                                              1. PTSD
                                                                                                                1. Anxiety Disorders
                                                                                                                  1. Substance Use Disorders
                                                                                                                  2. By Formulation:
                                                                                                                    1. Synthetic Psilocybin
                                                                                                                      1. Natural Psilocybin
                                                                                                                      2. By End-Use:
                                                                                                                        1. Hospitals
                                                                                                                          1. Specialized Clinics
                                                                                                                            1. Research Institutions
                                                                                                                            2. By Distribution Channel:
                                                                                                                              1. Direct Clinical Distribution
                                                                                                                                1. Research Supply Channels
                                                                                                                              2. China
                                                                                                                                1. By Treatment Type:
                                                                                                                                  1. TRD
                                                                                                                                    1. MDD
                                                                                                                                      1. PTSD
                                                                                                                                        1. Anxiety Disorders
                                                                                                                                          1. Substance Use Disorders
                                                                                                                                          2. By Formulation:
                                                                                                                                            1. Synthetic Psilocybin
                                                                                                                                              1. Natural Psilocybin
                                                                                                                                              2. By End-Use:
                                                                                                                                                1. Hospitals
                                                                                                                                                  1. Specialized Clinics
                                                                                                                                                    1. Research Institutions
                                                                                                                                                    2. By Distribution Channel:
                                                                                                                                                      1. Direct Clinical Distribution
                                                                                                                                                        1. Research Supply Channels
                                                                                                                                                      2. Korea
                                                                                                                                                      3. Japan
                                                                                                                                                      4. India
                                                                                                                                                      5. Australia
                                                                                                                                                      6. Singapore
                                                                                                                                                      7. Taiwan
                                                                                                                                                      8. South East Asia
                                                                                                                                                      9. Rest of Asia-Pacific
                                                                                                                                                    3. Middle East and Africa
                                                                                                                                                      1. Market Size and Forecast
                                                                                                                                                        1. By Treatment Type:
                                                                                                                                                          1. TRD
                                                                                                                                                            1. MDD
                                                                                                                                                              1. PTSD
                                                                                                                                                                1. Anxiety Disorders
                                                                                                                                                                  1. Substance Use Disorders
                                                                                                                                                                  2. By Formulation:
                                                                                                                                                                    1. Synthetic Psilocybin
                                                                                                                                                                      1. Natural Psilocybin
                                                                                                                                                                      2. By End-Use:
                                                                                                                                                                        1. Hospitals
                                                                                                                                                                          1. Specialized Clinics
                                                                                                                                                                            1. Research Institutions
                                                                                                                                                                            2. By Distribution Channel:
                                                                                                                                                                              1. Direct Clinical Distribution
                                                                                                                                                                                1. Research Supply Channels
                                                                                                                                                                              2. UAE
                                                                                                                                                                                1. By Treatment Type:
                                                                                                                                                                                  1. TRD
                                                                                                                                                                                    1. MDD
                                                                                                                                                                                      1. PTSD
                                                                                                                                                                                        1. Anxiety Disorders
                                                                                                                                                                                          1. Substance Use Disorders
                                                                                                                                                                                          2. By Formulation:
                                                                                                                                                                                            1. Synthetic Psilocybin
                                                                                                                                                                                              1. Natural Psilocybin
                                                                                                                                                                                              2. By End-Use:
                                                                                                                                                                                                1. Hospitals
                                                                                                                                                                                                  1. Specialized Clinics
                                                                                                                                                                                                    1. Research Institutions
                                                                                                                                                                                                    2. By Distribution Channel:
                                                                                                                                                                                                      1. Direct Clinical Distribution
                                                                                                                                                                                                        1. Research Supply Channels
                                                                                                                                                                                                      2. Turky
                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                    3. LATAM
                                                                                                                                                                                                      1. Market Size and Forecast
                                                                                                                                                                                                        1. By Treatment Type:
                                                                                                                                                                                                          1. TRD
                                                                                                                                                                                                            1. MDD
                                                                                                                                                                                                              1. PTSD
                                                                                                                                                                                                                1. Anxiety Disorders
                                                                                                                                                                                                                  1. Substance Use Disorders
                                                                                                                                                                                                                  2. By Formulation:
                                                                                                                                                                                                                    1. Synthetic Psilocybin
                                                                                                                                                                                                                      1. Natural Psilocybin
                                                                                                                                                                                                                      2. By End-Use:
                                                                                                                                                                                                                        1. Hospitals
                                                                                                                                                                                                                          1. Specialized Clinics
                                                                                                                                                                                                                            1. Research Institutions
                                                                                                                                                                                                                            2. By Distribution Channel:
                                                                                                                                                                                                                              1. Direct Clinical Distribution
                                                                                                                                                                                                                                1. Research Supply Channels
                                                                                                                                                                                                                              2. Brazil
                                                                                                                                                                                                                                1. By Treatment Type:
                                                                                                                                                                                                                                  1. TRD
                                                                                                                                                                                                                                    1. MDD
                                                                                                                                                                                                                                      1. PTSD
                                                                                                                                                                                                                                        1. Anxiety Disorders
                                                                                                                                                                                                                                          1. Substance Use Disorders
                                                                                                                                                                                                                                          2. By Formulation:
                                                                                                                                                                                                                                            1. Synthetic Psilocybin
                                                                                                                                                                                                                                              1. Natural Psilocybin
                                                                                                                                                                                                                                              2. By End-Use:
                                                                                                                                                                                                                                                1. Hospitals
                                                                                                                                                                                                                                                  1. Specialized Clinics
                                                                                                                                                                                                                                                    1. Research Institutions
                                                                                                                                                                                                                                                    2. By Distribution Channel:
                                                                                                                                                                                                                                                      1. Direct Clinical Distribution
                                                                                                                                                                                                                                                        1. Research Supply Channels
                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                      6. Rest of LATAM
                                                                                                                                                                                                                                                  2. Competitive Landscape, 2025
                                                                                                                                                                                                                                                    1. Introduction
                                                                                                                                                                                                                                                    2. Psilocybin Assisted Therapy Market Share Analysis, 2025 (%)
                                                                                                                                                                                                                                                      1. Market Share Analysis, 2025
                                                                                                                                                                                                                                                      2. Competition Ranking, 2025
                                                                                                                                                                                                                                                      3. Key Developments & Growth Strategies
                                                                                                                                                                                                                                                        1. Merger & Acquisition
                                                                                                                                                                                                                                                        2. Product Launch
                                                                                                                                                                                                                                                        3. Expansion
                                                                                                                                                                                                                                                      4. Consolidated SWOT Analysis of Key Players
                                                                                                                                                                                                                                                  3. Company Profile
                                                                                                                                                                                                                                                    1. MAPS Public Benefit Corporation
                                                                                                                                                                                                                                                      1. Business Overview
                                                                                                                                                                                                                                                      2. Financial Data
                                                                                                                                                                                                                                                      3. Key Product Categories
                                                                                                                                                                                                                                                      4. Recent Developments
                                                                                                                                                                                                                                                    2. COMPASS Pathways plc
                                                                                                                                                                                                                                                    3. Cybin Inc.
                                                                                                                                                                                                                                                    4. MindMed Inc.
                                                                                                                                                                                                                                                    5. ATAI Life Sciences
                                                                                                                                                                                                                                                    6. Field Trip Health Ltd.
                                                                                                                                                                                                                                                    7. Numinus Wellness Inc.
                                                                                                                                                                                                                                                    8. Beckley Waves
                                                                                                                                                                                                                                                    9. Mydecine Innovations Group
                                                                                                                                                                                                                                                    10. Bright Minds Biosciences